Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bor-Sheng Ko

Showing results (111-120 of 156) with videos related to

Pageof 16
Sort By:
Blood|March 2, 2013
Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemiaChieh-Lung Cheng, Hsin-An Hou, Ming-Cheng Lee, et al.
Blood|August 31, 2012
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolutionShang-Ju Wu, Yuan-Yeh Kuo, Hsin-An Hou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2023
Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE StudyDavid Bernard Miklos, Mohammad Abu Zaid, Julian P Cooney, et al.
Plos One|June 11, 2015
High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in TaiwanJih-Luh Tang, Hsiang-Chi Kung, Weng-Chi Lei, et al.
Clinical Epigenetics|April 6, 2018
Dynamics of <i>DNMT3A</i> mutation and prognostic relevance in patients with primary myelodysplastic syndromeMing-En Lin, Hsin-An Hou, Cheng-Hong Tsai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 14, 2025
Joint position statement of the diagnosis and management of light chain amyloidosis and light chain cardiac amyloidosis by the Taiwan Society of Cardiology (TSOC) and the Hematology Society of Taiwan (HST)Yen-Wen Wu, Chao-Hung Wei, Yen-Hung Lin, et al.
American Journal of Hematology|July 18, 2013
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progressionShang-Ju Wu, Jih-Luh Tang, Chien-Ting Lin, et al.
Hematological Oncology|January 24, 2025
Comprehensive Characterization of Overt Myelofibrosis in an Asian Cohort: Phenotype, Mutation Landscape and Discordance Among Scoring SystemsYu-Sung Chang, Yu-Hung Wang, Chao-Hung Wei, et al.
Blood Cancer Journal|January 4, 2023
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AMLXavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, et al.
British Journal of Haematology|September 10, 2025
Taiwan consensus on pulmonary chronic graft-versus-host disease: A joint statement from the Taiwan Society of Blood and Marrow Transplantation (TBMT) and Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM)Xavier Cheng-Hong Tsai, Zong-Han Yao, Shu-Wei Chou, et al.
Pageof 16

Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Blood|March 2, 2013
Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemiaChieh-Lung Cheng, Hsin-An Hou, Ming-Cheng Lee, et al.
Blood|August 31, 2012
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolutionShang-Ju Wu, Yuan-Yeh Kuo, Hsin-An Hou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2023
Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE StudyDavid Bernard Miklos, Mohammad Abu Zaid, Julian P Cooney, et al.
Plos One|June 11, 2015
High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in TaiwanJih-Luh Tang, Hsiang-Chi Kung, Weng-Chi Lei, et al.
Clinical Epigenetics|April 6, 2018
Dynamics of <i>DNMT3A</i> mutation and prognostic relevance in patients with primary myelodysplastic syndromeMing-En Lin, Hsin-An Hou, Cheng-Hong Tsai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 14, 2025
Joint position statement of the diagnosis and management of light chain amyloidosis and light chain cardiac amyloidosis by the Taiwan Society of Cardiology (TSOC) and the Hematology Society of Taiwan (HST)Yen-Wen Wu, Chao-Hung Wei, Yen-Hung Lin, et al.
American Journal of Hematology|July 18, 2013
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progressionShang-Ju Wu, Jih-Luh Tang, Chien-Ting Lin, et al.
Hematological Oncology|January 24, 2025
Comprehensive Characterization of Overt Myelofibrosis in an Asian Cohort: Phenotype, Mutation Landscape and Discordance Among Scoring SystemsYu-Sung Chang, Yu-Hung Wang, Chao-Hung Wei, et al.
Blood Cancer Journal|January 4, 2023
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AMLXavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, et al.
British Journal of Haematology|September 10, 2025
Taiwan consensus on pulmonary chronic graft-versus-host disease: A joint statement from the Taiwan Society of Blood and Marrow Transplantation (TBMT) and Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM)Xavier Cheng-Hong Tsai, Zong-Han Yao, Shu-Wei Chou, et al.
Pageof 16